In a randomized, controlled
clinical trial, 137 women who experienced two or more UTIs treated with
antibiotic in the previous 12 months were
selected to receive either 500 mg of Cran-Max® or 100 mg of trimethoprim per
day for six months. The researchers
found that the time ofrst recurrence of
the UTI was not signi cantly different between groups. The researchers
concluded that in therst head-to-head,
double-blind comparison of cranberry versus antibiotic prophylaxis,
trimethoprim had a very limited advantage over Cran-Max in the prevention of recurrent UTIs in older
women, while Cran-Max produced none of the adverse effects associated with
trimethoprim, including diarrhea, upset stomach and yeast infection. In
addition, trimethoprim is contraindicated for warfarin and should not be taken
together.

UtyMax® is a medical food.
Use under supervision of a quali ed healthcare professional.